Wolfgang Oster

Oncoceutics, Inc.

$4,522,969

Attributed

$4,522,969

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.2M · FY2015–18

$2.5M$1.9M$1.3M$625K$0

'15

'16

'17

'18

Funding mix

By agency

NIH$3,776,619 · 2

FDA$746,350 · 1

By mechanism

R44$3,776,619 · 2

R01$746,350 · 1

Top collaborators

No co-investigators on record.

Most similar at Oncoceutics, Inc.

Same institution · by research overlap

Joshua E. Allen$2,775,850

Others in their field

Top investigators on “Safety”

David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
Mitchell J Malone · Texas A&M Research Foundation$329,191,208
Gary D Acton · University Of California-Davis$320,373,312
Melynda Holmes · Technical Resources Inc$232,659,786
Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316

Research focus

SafetyRefractoryReceptorResponseRecurrencePhase Ii TrialClinical TrialsEnrollmentMutateMalignant NeoplasmsOralNovel TherapeuticsApoptosisPharmaceutical PreparationsAdvanced Malignant NeoplasmCancer PatientBaseDoseIn VitroCancer CellCellsIn VivoClinical EfficacyScreening